{"id":"W4408019919","doi":"10.1016/j.jaip.2025.02.024","title":"Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)","year":2025,"lang":"en","type":"article","venue":"The Journal of Allergy and Clinical Immunology In Practice","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Ottawa Allergy Research Corporation; BC Children's Hospital; University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Sanofi Genzyme; Food Allergy Canada; Bausch Health; Pfizer; Moderna; Incyte; Regeneron Pharmaceuticals; National Institutes of Health; AstraZeneca; Allergy Therapeutics; Novavax; Celgene; BioCryst; National Eczema Association; Dermira; Astellas Pharma; Ionis Pharmaceuticals; Galderma; Aimmune Therapeutics; Eli Lilly and Company; CSL Behring; Genentech; Mead Johnson Nutrition; Sanofi","keywords":"Medicine; Peanut allergy; Term (time); Open label; Immunotherapy; Allergic reaction; Dermatology; Immunology; Allergy; Internal medicine; Adverse effect; Food allergy; Immune system","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003952033,0.000775735,0.001561115,0.000334823,0.0003651337,0.0006535834,0.0006456025,0.001383616,0.002795344],"category_scores_gemma":[0.002384751,0.0004111254,0.001617401,0.000259964,0.001036844,0.0009010543,0.0005766738,0.002468495,0.0004605666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005453869,"about_ca_system_score_gemma":0.0006964755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004059763,"about_ca_topic_score_gemma":0.0007150764,"domain_scores_codex":[0.9981462,0.001133862,0.0001153453,0.0002064283,0.0002468565,0.0001513259],"domain_scores_gemma":[0.9969279,0.0007800172,0.001362502,0.0003303048,0.0002032212,0.0003959683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7893242,0.06118676,0.02398603,0.002268422,0.0019692,0.0003308217,0.0006729821,0.000986077,0.02783386,0.0001774454,0.001065156,0.09019894],"study_design_scores_gemma":[0.2497514,0.6964764,0.04572011,0.0001072495,0.0007325393,0.0004221795,0.0001089505,0.0004097125,0.003972287,0.00008458798,0.002174904,0.00003973318],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967917,0.001530402,0.0002079934,0.00008578444,0.00002181569,0.0005526401,0.0003948674,0.00001795674,0.0003968685],"genre_scores_gemma":[0.995123,0.001046321,0.001022955,0.0001940367,0.0001430063,0.001073715,0.0006462268,0.00001068047,0.0007400377],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003952033,"threshold_uncertainty_score":0.02090055,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04865613072070103,"score_gpt":0.4333925339023679,"score_spread":0.3847364031816669,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}